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The adenovirus type 12 (Ad12) E1A12S oncoprotein utilizes the cAMP/protein kinase A (PKA) signal transduction pathway
to activate expression of the viral E2 gene, the products of which are essential for viral replication. A central unsolved
question is, however, whether E1A12S interacts directly with PKA in the process of promoter activation. We show here that
E1A12S binds to the regulatory subunits (R) of PKA in vitro and in vivo. Interaction depends on the N-terminus and the
conserved region 1 (CR1) of E1A12S. Both domains are also essential for the activation of viral E2 gene expression. Infection
of cells with Ad12 leads to the cellular redistribution of RIIa from the cytoplasm into the nucleus. Furthermore, RIIa is also
located in the nucleus of cells transformed by E1 of Ad12 and transient expression of E1A12S leads to the redistribution of
RIIa into the nucleus in a N-terminus- and CR1-dependent manner. Cotransfection of E1A12S with RIIa results in strong
activation of the E2 promoter. Based on these results we conclude that E1A12S functions as a viral A-kinase anchoring protein
redistributing RIIa from the cytoplasm into the nucleus where it is involved in E1A12S-mediated activation of the E2 promoter.
© 2001 Academic Press
Key Words: adenovirus; A-kinase anchoring proteins; E2; E1A; PKA; regulation of gene expression.
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cINTRODUCTION
Expression of the early transcription unit 1A (E1A) is of
vital importance for adenoviruses (Ads), as this gene
encodes for transcription factors essential for the ex-
pression of viral and cellular genes, the products of
which are involved in viral reproduction and cellular
transformation (Bayley and Mymryk, 1994; Flint and
Shenk, 1997). E1A of the oncogenic serotype Ad12 gives
rise to five proteins among which the 266R (henceforth
referred to as E1A13S) and the 235R protein (E1A12S) are
he most dominant forms (Brockmann and Esche, 1995).
oth proteins differ only in the presence of the strong
ransactivation domain conserved region (CR) 3, which is
bsent in E1A12S. Together with CR1, CR2, and the non-
onserved amino terminus, this region fulfils most of the
ene regulatory functions. However, as E1A proteins do
ot bind sequence specifically to DNA (Ferguson et al.,
985), they modulate gene expression by targeting dif-
erent classes of cellular factors among other general
ranscription factors (e.g., TBP, RAP30; Song et al., 1995,
1997; Lipinski et al., 1998), sequence-specific transcrip-
ion factors (e.g., CREB, ATF-1; Liu and Green, 1994; Fax
t al., 2000b), repressors of transcription factors, (e.g. Rb;
1 To whom correspondence and reprint requests should be ad-
ressed at the Institute of Molecular Biology, University of Essent
C
edical School, Hufelandstrasse 55, 45122 Essen, Germany. Fax: 49-
01-7235974. E-mail: dieter.brockmann@uni-essen.de.
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30hyte et al., 1988; Bagchi et al., 1990; Bandara and La
Thangue, 1991), and cofactors (e.g., p300/CBP, PCAF; Yee
and Branton, 1985; Eckner et al., 1994; Arany et al., 1995;
Lundblad et al., 1995; Reid et al., 1998).
Several viral and cellular genes important for viral
reproduction are activated through cAMP response ele-
ments (CREs). Therefore, the cAMP/protein kinase A
(PKA) signal transduction pathway with its nuclear me-
diators CREB and ATF-1 is one important target for Ad12
E1A functions. There are two main classes of PKA, type
I and type II, which share a common catalytic (C)-subunit
but contain different regulatory (R)-subunits (RI and RII,
respectively) (Taske´n et al., 1997). Four R isoforms (RIa,
RIb, RIIa, RIIb) differ in their cAMP-binding affinities and
n their localization in the cell. Three distinct C-subunits
Ca, Cb, and Cg) have also been isolated. Although there
are subtle differences in the kinetic characteristics and
cAMP sensitivities of Ca- and Cb-containing holoen-
ymes, both isoforms are virtually indistinguishable with
espect to substrate specificity and interaction with R-
ubunits.
The inactive PKA holoenzyme consists of two C- and
wo R-subunits (Taske´n et al., 1997). Activation is me-
iated through a cooperative binding of two cAMP
olecules to each R-subunit, which results in the
iberation of both C-subunits. The C-subunits translo-
ate into the nucleus and phosphorylate target pro-eins like the cAMP response element binding protein
REB (Gonzales and Montminy, 1989). Phospho-CREB
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31INTERACTION OF E1A12S WITH PKA R-SUBUNITSin turn recruits the cofactor CREB binding protein
(CBP) to the CRE of target promoters (Chrivia et al.,
1993). CBP is then able to activate gene expression by
modifying chromatin and interacting with factors of the
general transcription machinery (Bannister and
Kouzarides, 1996; Ogryzko et al., 1996; Nakajima et al.,
1997).
A large portion of PKA-II is targeted to subcellular
components through association of the RII-subunits
with cellular adapter proteins known as A-kinase an-
choring proteins (AKAPs) (Dell’Acqua and Scott, 1997).
In contrast, the PKA-I holoenzyme is predominantly
soluble in the cytosol, although growing evidence sug-
gests that PKA-I might also be localized to specific
subcellular components through dual-specificity
AKAPs. It is assumed that this compartmentalization of
PKA to distinct subcellular loci as well as the compo-
sition of the PKA holoenzyme contributes to the spec-
ificity in cellular responses to extracellular signals
like growth factors, neurotransmitters, or cellular
stress.
Activation of the Ad12 E2 gene, which encodes
proteins essential for viral replication (Swaminathan
and Thimmapaya, 1995), is driven by the E2-CRE. We
have recently shown that E1A12S strongly activates
the E2-CRE in dependence on its N-terminus and
CR1 by assembling a ternary complex consisting of
CREB/ATF-1 (binding the E2-CRE), the cofactor CBP,
and E1A12S (Fax et al., 2000b). Most interestingly, acti-
vation is prevented through the PKA-specific inhibitor
PKI, which exports the C-subunit from the nucleus,
indicating that C-mediated phosphorylation of one or
more proteins involved in E2Ad12 promoter activation
lays an essential role. Therefore, the important ques-
ion arises of whether E1A12S interacts directly with
PKA in activation of the viral promoter. Using three
independent assays we show here that E1A12S binds to
the R-subunit of PKA in vitro and in vivo. Binding
epends on the N-terminus and CR1 of E1A12S. Both
domains are also necessary to activate the E2Ad12
promoter. Infection of cells with Ad12 leads to the
redistribution of RIIa from the cytoplasm into the nu-
cleus, whereas RIa remains cytoplasmic. In addition,
IIa is also located in the nucleus of cells transformed
by Ad12 E1 constitutively expressing E1A and in cells
transiently transfected with E1A12S. Redistribution of
IIa depends on the RIIa binding site in E1A12S,
namely the N-terminus and CR1. Most interestingly,
cotransfection of E1A12S with the RIIa subunit revealed
strong E2Ad12 promoter activation. These results sug-
est that E1A12S functions as a viral AKAP redistribut-
ing RIIa from the cytoplasm into the nucleus and that
RIIa itself is involved in the activation of the E2Ad12
promoter.
o
cRESULTS
The PKA inhibitor PKI and the Ht31 peptide that
disrupts PKA anchoring both block the transactivation
function of E1A12S on the E2Ad12 promoter
The E2 promoter of Ad12, which drives expression of
roteins essential for viral replication (Swaminathan and
himmapaya, 1995), contains a single CREB (E2-CRE)
nd a single E2F binding site (Fig. 1). Promoter activation
s mediated exclusively via the E2-CRE (located between
ucleotides 299 and 292 relative to the transcriptional
tart site), which is bound by a ternary complex consist-
ng of CREB-1/ATF-1, CBP, and E1A12S and depends on
the N-terminus and CR1 of the E1A12S protein (Fax et al.,
000b). The E2F site, however, is dispensable for pro-
oter activation, which is in contrast to the E2 promoter
FIG. 1. The PKA inhibitor PKI represses activation of the E2Ad12
promoter through E1A12S. The reporter construct E2Ad12-CAT (1 mg) was
cotransfected with expression vectors encoding for E1A12S (0.3 mg), PKI
(1.5 mg), a PKI mutant lacking the C binding site (PKImut; 1.5 mg), or a
combination of expression vectors, as indicated, in KB cells. pRc/RSV
was added to keep the amount of transfected DNA constant. Cells were
harvested 24 h later, and CAT activity was determined. The data shown
are representative of three independent transfections performed in
duplicate. The promoter activity of E2Ad12-CAT in the presence of pRc/
RSV was set as 1. The E2Ad12 promoter (nt 2140 to 11) construct is
schematically drawn at the top of the figure. Transcription factor bind-
ing sites and the TATA box are indicated.f Ad2 or Ad5, for which promoter induction requires
o-operation between the E2F and ATF transcription fac-
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32 FAX ET AL.tors (Swaminathan and Thimmapaya, 1995; Fax et al.,
2000b; Schaley et al., 2000).
CREB-mediated promoter activation includes at least
one phosphorylation step (Chivria et al., 1993; Cardinaux
et al., 2000). The question arises, therefore, of whether
E1A12S interacts with components of the PKA holoenzyme
n the process of E2Ad12 promoter activation. To address
this question we made use of the PKA-specific inhibitor
PKI, which inhibits catalytic activity and exports the C-
subunit from the nucleus (Wen et al., 1995). The E2Ad12-
AT reporter construct (Fig. 1) was cotransfected with
xpression vectors for E1A12S and/or the PKA inhibitor
PKI into KB cells. E1A12S is a strong activator of CAT gene
xpression from E2Ad12-CAT (Fig. 1; Lipinski et al., 1997;
Fax et al., 2000b). Interestingly, PKI efficiently inhibits
basal as well as E1A12S-induced E2 promoter activation
Fig. 1; Fax et al., 2000b). In contrast, a PKI mutant, which
s unable to bind to the C-subunit (Day et al., 1989),
epressed neither basal nor E1A12S-activated CAT gene
expression (Fig. 1), indicating that phosphorylation of
one or more nuclear factors by the C-subunit plays an
important role in E2Ad12 promoter activation. Similar re-
sults were obtained using the kinase inhibitor H89 (data
not shown).
One possibility of how E1A12S might interfere with the
ctivity of the PKA holoenzyme is via influence of its
ubcellular localization. To prove this hypothesis we
sed anchoring inhibitor peptides that have been proven
o be valuable tools for analyzing the role of PKA anchor-
ng in cAMP-responsive cellular events (Lester and Scott,
997). Such inhibitors contain the R-binding domain but
o targeting domain and displace and solubilize PKA by
ompetition with endogenous AKAPs. The human thy-
oid-anchoring protein Ht31 binds to the RII-subunit of
KA (Carr et al., 1991, 1992). Coexpression of an Ht31
fragment spanning the RII-binding site (aa 418–718)
leads to repression of E1A12S-induced CAT gene expres-
sion (Fig. 2). Interestingly, the mutant Ht31-P, in which the
amphipathic helix necessary for binding to RII was de-
stroyed by a point mutation (Carr et al., 1991), did not
prevent E2Ad12 promoter activation through E1A12S (Fig. 2).
These results were confirmed by cotransfecting of cDNA
coding for amino acids 326–425 of the AKAP-149 (data
not shown), which spans the RI and RII interaction motif
(Lin et al., 1995; Trendelenburg et al., 1996; Huang et al.,
997). From these data we conclude that a functional
nteraction between the E1A12S protein and the PKA ho-
loenzyme is essential for activation of the E2Ad12 promoter
nd may depend on anchoring of PKA.
1A12S binds RIa and RIIa in vitro and in vivo
The finding that soluble fragments of AKAPs like Ht31
inhibit E1A12S-mediated activation of the E2Ad12 promoterrompted us to investigate whether the R-subunits inter-
ct physically with the adenoviral protein. GST pull-downnalyses were performed using bacterially expressed
nd purified GST-E1A12S fusion proteins and in vitro tran-
scribed/translated RIa or RIIa. We show that GST-E1A12S
efficiently pulls down labeled RIa and RIIa (Figs. 3A and
B, lane 3). As the GST leader sequence does not bind
he R-subunits (Figs. 3A and 3B, lane 2), we conclude
hat the association is mediated through the adenoviral
art of the fusion protein. Furthermore, deletion of the
1A12S N-terminus or CR1, which are both necessary for
he activation of the E2Ad12 promoter, results in complete
oss of (in the case of CR1 deletion; Figs. 3A and 3B, lane
) or greatly reduced (in the case of N-terminal deletion;
igs. 3A and 3B, lane 4) binding of RIa and RIIa, respec-
ively.
To demonstrate that the interaction between the ad-
noviral protein and the R-subunits is direct and not
ediated via a factor present in the reticulocyte lysate
sed for in vitro transcription/translation, we incubated
ST-E1A12S with bacterially expressed and purified RIa
or RIIa that were removed from the GST leader sequence
by proteolytic cleavage. Bound RIa and RIIa were de-
ected by Western blotting using anti-RIa- or anti-RIIa-
pecific antibodies. These assays showed that E1A12S
FIG. 2. The anchoring inhibitor peptide Ht31 counteracts E1A12S-
mediated activation of the E2Ad12 promoter. The reporter construct
E2Ad12-CAT (1 mg) was cotransfected with expression vectors encod-
ing for E1A12S (0.3 mg), a Ht31 soluble fragment spanning the RII
inding site (aa 418–718; 1 mg), or the point-mutated Ht31-P (1 mg),
s indicated, in KB cells. pRc/RSV and pcDNA3.1 were added to
eep the amount of transfected DNA constant. Cells were harvested
4 h later, and CAT activity was determined. The data shown are
epresentative of three independent transfections performed in du-
licate. The promoter activity of E2Ad12-CAT in the presence of pRc/
SV was set as 1.binds directly to both R-subunits (Fig. 3C, lanes 1 and 3).
Deletion of the AKAP interaction domain from RIa (aa
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33INTERACTION OF E1A12S WITH PKA R-SUBUNITS1–45; Leon et al., 1997) or RIIa (aa 1–57; Hausken et al.,
1996; Newlon et al., 1999) abolished the interaction with
E1A12S (Fig. 3C, lanes 2 and 4). Most interestingly, addi-
ion of the Ht31 anchoring competitor peptide at a con-
FIG. 3. E1A12S binds directly to RIa and RIIa in vitro. (A) In vitro
translated 35S-labeled RIa was incubated with the protein leader se-
uence GST (lane 2) or various GST-E1A12S fusion proteins as indicated
(lanes 3–6). Bound proteins were eluted and analyzed on 10% SDS–
polyacrylamide gels followed by fluorography. Lane 1 represents 10%
input of 35S-RIa. (B) In vitro translated 35S-labeled RIIa was incubated
ith the protein leader sequence GST (lane 2) or various GST-E1A12S
fusion proteins as indicated (lanes 3–6). Lane 1 represents 10% input of
35S-RIIa. (C) Bacterially expressed and purified RIa (lane 1), DRIa
(lacking aa 1–45; lane 2), RIIa (lane 3), or DRIIa (lacking aa 1–57; lane
) was incubated with an equimolar amount of bacterially expressed
nd purified GST-E1A12S (1 mM each). Bound RIa and RIIa were ana-
lyzed on 10% SDS–polyacrylamide gels and detected by Western blot-
ting using anti-RIa- (P53620) or anti-RIIa- (P55120) specific antibodies.
(D) Bacterially expressed and purified RIIa was incubated with bacte-
rially expressed and purified GST-E1A12S in the presence of 100 nM
Ht31 anchoring competitor peptide (lane 2) or a control peptide (Ht31-P;
lane 1). Bound RIIa was analyzed on 10% SDS–polyacrylamide gels and
detected by Western blotting using an anti-RIIa-specific antibody
P55120).entration of 100 nM to the incubation mixture prevents
lso the binding of RIIa to E1A12S (Fig. 3D, lane 2). Themutant Ht31-P peptide, which did not repress E1A12S-
nduced activation of the E2Ad12 promoter (Fig. 2), did not
inhibit association between E1A12S and RIIa (Fig. 3D, lane
). These data indicate that Ht31 and E1A12S might bind to
verlapping or identical sites in the AKAP binding do-
ain from RIIa. However, these results do not exclude
that Ht31 binds to the adenoviral protein and blocks in
this way the interaction with RIIa. Moreover, we ob-
erved weaker binding of E1A12S to RIIb and no interac-
ion with RIb in GST pull-down assays (data not shown).
Finally, addition of the C-subunit did not affect or com-
pete with the R interaction with E1A12S (data not shown).
hese data demonstrate that E1A12S binds directly to the
RIa and RIIa subunits in vitro.
To confirm that E1A12S interacts with the R-subunits in
vivo we carried out yeast SOS–two-hybrid interaction
assays in which protein–protein interactions are indi-
cated by selective yeast growth at 36°C (Aronheim et al.,
1997). The cDNA for RIa or RIIa was cloned into the myr
fusion protein expression vector pYes/MYR and cotrans-
fected with either a SOS-E1A12S wild type or a SOS-E1A12S
mutant fusion protein expression vector in yeast cdc25-2
cells, which were subsequently tested for growth under
the selective temperature of 36°C. The E1A12S wild-type
rotein as well as the E1A12S N-terminus interacted
trongly with RIa in the yeast system (Fig. 4A). SOS-1-79
(containing the N-terminus and CR1 of E1A12S) also
bound to RIa (Fig. 4A). However, yeast growth was re-
roducibly reduced at the selective temperature. The
eason for this growth reduction is not yet clear, but it is
ften observed using SOS-1-79 as bait in the SOS–two-
ybrid screen (see, for instance, Lipinski et al., 1999). In
ontrast, no interaction was observed using the CR1
omain of E1A12S (Fig. 4A). Moreover, deletion of amino
acids 1–91 from RIa prevented interaction with either the
1A12S wild-type protein or the E1A12S N-terminus (Fig.
A). Identical results were obtained by cotransfecting
OS-E1A12S with an expression vector encoding MYR-
IIa into cdc25-2 cells. The E1A12S wild-type protein, the
1A12S N-terminus, and aa 1–79 of E1A12S bound to amino
cids 1–91 of RIIa (Fig. 4B). As the SOS-E1A12S mutants
did not give rise to yeast growth under selective condi-
tions in combination with the empty MYR expression
vector (Figs. 4A and 4B), these data confirm our results
obtained in GST pull-down assays. Furthermore, they
indicate that the N-terminus of E1A12S (aa 1–29) on its
own is able to bind to the N-termini of RIa and RIIa.
Next, we wanted to establish whether E1A12S binds to
RIa and RIIa in mammalian cells. We performed immu-
oprecipitations from extracts of COS7 cells transfected
ith an expression vector encoding for an E1A12S-Myc/
His-tagged fusion protein. Immunoprecipitations were
carried out with anti-RIa or anti-RIIa antibodies and in-
eracting E1A12S was identified by Western blot analysesusing an anti-E1A antiserum. These experiments re-
vealed that E1A12S coprecipitates with RIa and RIIa from
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34 FAX ET AL.COS7 cells (Fig. 5A, lanes 3 and 4). Moreover, the E1A12S-
yc/His fusion protein was efficiently precipitated using
n anti-Myc mouse monoclonal antibody (Fig. 5A, lane 2).
o E1A12S-specific signal was detected in mock-trans-
fected cells using a control antibody (nonimmune rabbit
IgG; Fig. 5A, lane 1). Figure 5B (lanes 2–4) confirms
expression of E1A12S in the transiently transfected COS7
cells and Fig. 5C demonstrates the endogenous concen-
tration of RIa (lane 2) and RIIa (lane 1) in COS7 cells.
FIG. 4. The N-terminus of E1A12S interacts with the AKAP binding site
of the RIa and RIIa subunits in the yeast SOS–two-hybrid system.
Cdc25-2 cells were cotransformed with the indicated E1A12S-SOS fusion
(pADNS/SOS) and RIa-MYR fusion (pYES/Myr; A) or RIIa-MYR fusion
(B) expression plasmids, plated onto YNB-glucose minimal medium,
and grown for 3 days under nonselective conditions at 25°C. Thereaf-
ter, four independent transformants were picked, grown at 25°C on
YNB-glucose minimal medium, replica plated onto YNB-(1)-galactose
minimal plates, and then grown at the interaction-selective temperature
of 36°C.Taken together, these data clearly show that E1A12S binds
o RIa and RIIa in vitro and in vivo.Expression of E1A12S correlates with a redistribution
f RIIa into the nucleus
To explore whether the interaction between E1A12S and
PKA has any impact in vivo, we infected KB and COS7
cells with Ad12. Twenty hours postinfection, cells were
fixed and analyzed for distribution of PKA by immunoflu-
FIG. 5. E1A12S interacts with RIa and RIIa in vivo. (A) COS7 cells were
either transfected with an E1A12S-myc/his expression vector (lanes 2–4)
r mock transfected (lane 1). Cells were lysed 48 h later, and pre-
leared extracts were incubated with an anti-myc antibody (lane 2), an
nti-RIIa antibody (C20, lane 3), an anti-RIa antibody (C19, lane 4), or an
nrelated antiserum (normal rabbit IgG, lane 1). Immune complexes
ere analyzed on 13% SDS–polyacrylamide gels followed by Western
lotting using an anti-Ad12 E1A antiserum. The position of the E1A12S
protein is indicated on the right. (B) The expression of E1A12S in the
transiently transfected cells described under (A) was checked by West-
ern blot analyses using an anti-Ad12 E1A antiserum. The position of the
E1A12S protein is indicated on the right. (C) The amount of endog-
nously expressed RIIa (lane 1) and RIa (lane 2) in COS7 cells was
analyzed by Western blotting. The positions of the R-subunits are
indicated.
nw
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35INTERACTION OF E1A12S WITH PKA R-SUBUNITSorescence. As shown in Figs. 6A and 6B, infections of KB
or COS7 cells lead to a redistribution of RIIa from the
cytoplasm into the nucleus (left column, purple), whereas
RIIa stayed associated with granular cytoplasmic struc-
tures in mock-infected cells (right column, red; the nu-
FIG. 6. Expression of E1A12S leads to a redistribution of RIIa into the
or mock infected (right column). Twenty hours later, cells were fixed an
staining) and counterstained for DNA by Hoechst 33342. Dual image
distribution of RIIa (left column) and RIa (right column) in the Ad12 E1-tr
cells (lane 1) and Ad12-infected KB cells (lane 3) was analyzed by West
of the Ad12 E1A proteins are indicated on the left. Lane 2 represents e
carrying either the FLAG epitope alone (top and middle rows, left column
ere fixed and distribution of FLAG (green) and PKA RIIa (red, top row
mage overlays are shown. Bottom row: Cells transfected with myc-ta
distribution of myc epitope (green) and PKA RIIa (red). Bars, 10 mm.cleus is indicated by the blue DNA staining). Surprisingly,
the distribution of RIa was not affected by Ad12 infection
t
y(Figs. 6A and 6B). Next, we analyzed the distribution of
RIIa and RIa in the human HEK12 cell line, which is
transformed by E1 of Ad12 and expresses constitutively
E1A (Whittaker et al., 1984). Again, RIIa is located in the
ucleus (Fig. 6C, left column), whereas RIa is found in
. KB cells (A) and COS7 cells (B) were infected with Ad12 (left column)
yzed for distribution of PKA RIIa and RIa by immunofluorescence (red
ays are shown (purple indicates image overlap). (C) Analysis of the
ed HEK12 cell line. (D) Expression of Ad12 E1A in transformed HEK12
tting using a polyclonal sheep anti-Ad12 E1A antiserum. The positions
f mock-infected KB cells. (E) COS7 cells were transfected with vectors
FLAG-tagged E1A12S protein (top and middle rows, right column). Cells
A RIa (red, middle row) was examined by immunofluorescence. Dual
E1A12S wild type (left) or mutant D1-79/E1A12S were examined for thenucleus
d anal
overl
ansform
ern blo
xtract o
) or the
) or PK
ggedhe cytoplasm (Fig. 6C, right column). Western blot anal-
ses demonstrated E1A expression in infected and
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36 FAX ET AL.transformed cells (Fig. 6D). We therefore conclude that
RIIa is located in the nucleus of Ad12-infected and Ad12
1-transformed cells.
To investigate whether E1A12S might be responsible for
he redistribution of RIIa, we expressed the E1A12S pro-
tein fused to two different epitope tags in COS7 cells and
examined the localization of E1A12S and PKA by immuno-
luorescence. The FLAG epitope alone was localized
ainly nuclearly (Fig. 6E, left column, top and middle row,
reen) and had no effect on the localization of RIIa (top
ow, red) or RIa (middle row, red), which remained cyto-
plasmic, as described elsewhere (Keryer et al., 1999). In
contrast, expression of FLAG-tagged E1A12S dramatically
edistributed RIIa from the cytoplasm to the nucleus,
here it colocalized with E1A12S, as shown on the image
verlay (Fig. 6E, right column, top row, yellow labeling).
xpression of E1A12S had no effect on the distribution of
Ia (Fig. 6E, middle row, right column). Furthermore,
expression of a myc-tagged E1A12S protein also induced
a relocalization of RIIa to the nucleus (Fig. 6E, bottom
ow, left column), whereas a mutant E1A12S protein lack-
ng the first 79 amino acids did not affect the distribution
f RIIa (Fig. 6E, bottom row, right column).
To independently assess the distribution of RIIa
observed in immunofluorescence analyses, we per-
formed Western blot experiments using nuclear and
cytoplasmic extracts of mock- (Figs. 7A and 7B, lane 1)
or E1A12S-transfected (Figs. 7A and 7B, lane 2) COS7
cells and respective antibodies. Figure 7A shows that
expression of E1A12S leads to an increase of RIIa in the
uclear extract (compare lane 1 with lane 2). At the
ame time, the amount of RIIa was reduced in the
ytoplasmic fraction (Fig. 7B). In contrast to these
esults, only marginal traces of RIa were detected in
the nuclear extracts of E1A12S-expressing and mock-
transfected cells (Fig. 7A). Interestingly, we observed
no increase in nuclear Ca by E1A12S expression (Fig.
A), which is in agreement with the data obtained in
he immunofluorescence experiments (data not
hown). Usage of an anti-E1A polyclonal antiserum
onfirmed the nuclear localization of E1A12S (Fig. 7A,
lane 2) as well as its presence in the cytoplasm (Fig.
7B, lane 2). Moreover, reprobing the blot with an anti-
CREB antibody demonstrated the blotting of identical
amounts of nuclear extracts obtained from mock- and
E1A12S-transfected cells (Fig. 7A, compare lane 1 with
lane 2), and usage of an anti-acetyl histone H4 anti-
body demonstrates the purity of the cytoplasmic and
nuclear fractions (Fig. 7C). Taken together, these data
show that expression of E1A12S results in a redistribu-
tion of RIIa into the nucleus. In contrast to these
esults, localization of RIa is not affected by E1A12S.The reason for the latter result is not yet clear and
needs further investigation.FIG. 7. Expression of E1A12S correlates with a redistribution of RIIa
into the nucleus. COS7 cells were either transfected with an E1A12S
expression vector (lane 2) or mock transfected (lane 1). Cells were
lysed 48 h later, and nuclear (A) and cytoplasmic (B) fractions were
prepared. Extracts were subjected to 12% SDS–polyacrylamide
gels followed by Western blot analyses using an anti-RIIa antibody
C20), an anti-RIa antibody (C19), a polyclonal sheep anti-Ad12 E1A
ntiserum, an anti-Ca antibody (C20), or an anti-CREB-1 antibody
(X12) as indicated on the right. (C) The quality of the subcellular
fractionation of nuclear (lane 1) and cytoplasmic (lane 2) extracts of
COS7 cells was analyzed using an anti-acetyl histone H4 anti-
body. The position of the acetylated H4 protein is indicated on the
left.
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37INTERACTION OF E1A12S WITH PKA R-SUBUNITSThe E2Ad12 promoter is strongly activated by
cotransfected E1A12S and RIIa
As expression of E1A12S correlates with a redistribution
of RIIa from the cytosol into the nucleus, we asked for a
functional consequence of this translocation on the
E1A12S-dependent activation of the E2Ad12 promoter. KB
cells were transiently transfected with the E2Ad12-CAT
reporter construct and expression vectors for E1A12S
and/or RIIa. Thereafter, CAT activity was determined. As
xpected, E1A12S efficiently activated the E2Ad12 promoter
8-fold; Fig. 8, cross-hatched bar). Transfection of RIIa
yielded only a slight but reproducible activation of re-
porter gene expression in the absence of E1A12S (2-fold;
Fig. 8, hatched bar). Most surprisingly, cotransfection of
E1A12S with RIIa strongly induced CAT gene expression
driven by the E2Ad12 promoter (approximately 20-fold; Fig.
, solid bar), indicating that the translocated RIIa subunit
ight play an active part in E2Ad12 promoter activation.
DISCUSSION
In this paper we present several lines of evidence
implicating the adenovirus E1A12S oncoprotein as a viral
KAP: (1) E1A12S interacts with the RIIa subunit of PKA in
vitro and in vivo, (2) the R-E1A12S interaction is com-
FIG. 8. Cotransfected E1A12S and RIIa strongly activate the E2Ad12
promoter. The reporter construct E2Ad12-CAT (1 mg) was cotransfected
ith expression vectors encoding for E1A12S (0.3 mg; cross-hatched
ar), RIIa (1.5 mg; hatched bar) or a combination of both (solid bar) in KB
cells. pRc/RSV and pcDNA3.1 were added to keep the amount of
transfected DNA constant. Cells were harvested 24 h later, and CAT
activity was determined. The data shown are representative for three
independent transfections performed in duplicate. The promoter activ-
ity of E2Ad12-CAT in the presence of pRc/RSV was set as 1 (open bar).petable with a peptide from the PKA binding domain of
the AKAP Ht31, which has been well established as an
manchoring disruption peptide, and (3) deletion mapping
outlines the R binding region in amino acids 1–79 of
E1A12S, which contains an amphipathic a-helical region
between aa 10 and aa 27 (LSYQEADDILEHLVDNFF;
Gedrich et al., 1992). This amphipathic helix shows some
homology (5 of 8 conserved residues) to the common
motif for RII binding domains (X{L, I, V}X3{A, S}X2{L, I, V}
{L, I, V}X2{L, I, V}{L, I, V}X2{A, S}{L, I, V}) as recently refined
by Carr and co-workers (Vijayaraghavan et al., 1999).
owever, Ser11, Phe26, and Phe27 of E1A12S do not
dhere to the homology. (4) Expression of E1A12S redis-
ributes PKA in the cell; (5) in transient expression as-
ays in which overexpression of E1A12S activates the E2
romoter in a PKA-dependent fashion, cotransfection
ith soluble fragments of the AKAPs Ht31 and AKAP149
hat disrupt anchoring also inhibits the stimulatory effect
f the E1A12S protein. In terms of specificity of E1A12S
interaction with the different PKA isoforms, in-solution
binding assays (GST precipitation experiments) were
performed. At the concentrations of the two partners
used in such assays (1 mM), stringency is limited by the
equilibrium binding constant and affinities below that
cannot readily be measured. The data showed solid
interaction of E1A12S with both RIIa and RIa, but a much
weaker interaction with RIIb and no interaction with RIb
(data not shown). Such different in vitro interactions, with
RIIa the preferred in vivo interaction partner, are ob-
served for dual-specific AKAPs S-AKAP84/D-AKAP1/
AKAP149 and D-AKAP2 (Lin et al., 1995; Huang et al.,
1999; Trendelenburg et al., 1996; Herberg et al., 2000).
Other AKAPs appear to have both RIIa/b and RIa binding
domains (e.g., FSC-1, AKAP110, hAKAP220) (Miki and
Eddy, 1998; Vijayaraghavan et al., 1999; Reinton et al.,
2000), and some (e.g., FSC-1, CE-AKAP) also bind RIa in
vivo through an RIa-specific interaction domain (Miki and
ddy, 1999; Angelo and Rubin, 2000). However, E1A12S, in
contrast to most other eukaryotic AKAPs, did not show
interaction in the solid phase overlay assay (RII overlay,
data not shown). This, together with the fact that the
amphipathic helix in amino acids 10 to 27 does not
adhere fully to the motif of conserved residues identified
in other RII binding AKAPs (Vijayaraghavan et al., 1999),
indicates that the virus protein may have an interaction
domain that is somewhat different from that of the pre-
viously characterized eukaryotic AKAPs. Indeed, some
eukaryotic AKAPs appear to be sensitive to denaturation
by SDS–PAGE and cannot be reconstituted to good bind-
ers in an R overlay assay (Dransfield et al., 1997; Miki
nd Eddy, 1999). Also, a different type of R-binding do-
ain with multiple leucine clusters is emerging from
haracterization of the pericentrin PKA binding domain
Diviani et al., 2000). PKA binding both to this different
omain and to the virus protein can be displaced by Ht31
nchoring disruption peptide, indicating a common
echanism of interaction with other AKAPs via the RIIa
N-terminus (Newlon et al., 1999).
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38 FAX ET AL.Binding of E1A12S to RIIa correlates with a redistribu-
tion of RIIa into the nucleus. Both E1A12S domains nec-
ssary for binding the regulatory subunit are also nec-
ssary for the translocation of RIIa into the nucleus.
Moreover, cotransfection of E1A12S with RIIa leads to a
strong activation of the E2Ad12 promoter. The question
arises of how RIIa participates in the activation of the
E2Ad12 promoter. The most simple model is that E1A12S-
ecruited RIIa functions as a coactivator on the E2Ad12
promoter. Published data show that RIIb binds directly
as well as in a complex with CREB to the CRE consensus
sequence and that an artificial Gal-RIIb fusion protein
ctivates a Gal-dependent reporter construct in transient
xpression assays in COS7 cells (Srivastava et al., 1998).
owever, the findings that RIIa failed to bind directly to
he CRE in these experiments (Srivastava et al., 1998)
nd that RIIa strongly activates the E2Ad12-promoter only
n the presence of the E1A12S protein (this paper) argue
against this hypothesis. A second model might be that
the adenoviral protein recruits the regulatory subunit to
the viral promoter, where it functions as an adapter for
the C-subunit. Once anchored to the promoter, catalytic
activity is needed for phosphorylation of factors involved
in E2Ad12 promoter activation. This hypothesis is in agree-
ent with our findings that cotransfection of E1A12S and
IIa results in a strong reporter gene expression and
hat PKI, which exports the catalytic subunit from the
ucleus (Wen et al., 1995), inhibits E1A12S-mediated acti-
vation of the E2Ad12 promoter. Moreover, it is consistent
with our preliminary unpublished observations that (1)
binding of E1A12S to RIIa does not lead to a dissociation
of the PKA holoenzyme in vitro (F. Herberg et al., unpub-
lished observation), (2) E1A12S pulls down PKA activity
rom cellular extracts, and (3) the C-subunit and E1A12S
coprecipitate from infected COS7 cells using an anti-Ca
antibody, although we did not observe a direct interac-
tion in GST pull-down assays. On the other hand, it is
well known that the kinase activity of the C-subunits of
PKA is inhibited by binding to R-subunits. Studies are
under way to elucidate the mechanism of how RIIa
interferes with the activation of the E2Ad12 promoter.
We have recently shown that the recruitment of a
ernary complex consisting of CREB/ATF-1, E1A12S, and
p300/CBP on the E2-CRE is essential for the activation of
the E2Ad12 promoter (Fax et al., 2000b). Moreover, we
ound that the E2Ad12 promoter is regulated in a histone
cetylation-dependent manner, and our results indicated
hat activation of the histone acetyltransferase activity of
300/CBP through E1A12S plays an important role in pro-
moter activation (Fax et al., 2000a). The results presented
here suggest, however, that recruitment of p300/CBP
HAT activity is not sufficient for strong E2Ad12 promoter
ctivation and that phosphorylation of one or more fac-
ors is necessary, too. Most importantly, our data dem-
nstrate that E1A12S fulfills a dual function in the activa-
tion process of the E2Ad12 promoter. First, it is involved inassembly of the multitranscription factor complex bound
to the E2-CRE, where it modulates the HAT activity of
p300/CBP. Second, it redistributes cytoplasmic RIIa to
the E2Ad12 promoter. RIIa, in turn, might recruit the C-
subunit, which is necessary for phosphorylation and
activation of one of the factors involved in promoter
activation.
MATERIALS AND METHODS
Plasmids
The bacterial and eukaryotic expression vectors en-
coding the E1A12S protein of Ad12 E1A or derived mutants
s well as the reporter construct E2Ad12-CAT have been
described (Brockmann et al., 1990; Lipinski et al., 1999;
Fax et al., 2000b). The expression vector encoding E1A12S
as a FLAG-tagged fusion was constructed by cloning the
respective cDNA amplified by PCR into the BamHI site of
CMV-FLAG-5a (Sigma). D1-79/E1A12S-myc lacking amino
acids 1–79 of E1A12S was constructed by subcloning the
respective BamHI fragment into pcDNA3.1-A-myc/his (In-
vitrogen). The pYes2 expression vector containing the
v-Src myristoylation signal and the pADNS expression
vector containing the hSOS catalytic domain were de-
scribed elsewhere (Aronheim et al., 1997). The pADNS
expression vector encoding the full-length E1A12S protein
fused to the hSOS catalytic domain was generated by
PCR. pADNS expression vectors that encode the various
E1A domains were described before (Lipinski et al.,
1999). PYes expression vectors that encode myristoy-
lated RIa, D1–91/RIa (lacking aa 1–91), RIIa, and D1–91/
RIIa (lacking aa 1–91) were constructed by cloning the
respective cDNAs amplified by PCR into the SmaI site of
pYes2. PcDNA3.1-Ht31 and pcDNA3.1-Ht31-P were de-
scribed elsewhere (Lester et al., 1997). PCR.3.1-RIa and
CR.3.1-RIIa were constructed by PCR using the TA clon-
ng kit of Invitrogen.
ell culture
KB (human oral epidermoid carcinoma), HEK12 (hu-
an embryo kidney cells transformed by the EcoRI-C
ragment of Ad12; Whittaker et al., 1984), and COS7
SV40-transformed African green monkey kidney cells)
ells were maintained in Dulbecco’s modified Eagle’s
edium supplemented with 10% fetal calf serum, peni-
illin, and streptomycin at 37°C and 5% CO2.
ransient expression assays
For transient expression assays, 2.5 3 105 KB cells
ere cotransfected with 1 mg of the E2Ad12 reporter con-
truct (E2Ad12-CAT) and different amounts of expression
vectors as indicated in the legends to the figures using
polyfectin according to the manufacturer’s instructions
(Biontex, Martinsried, Germany). Transfections were
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39INTERACTION OF E1A12S WITH PKA R-SUBUNITSstopped after 6 h and cells were harvested 24 h later to
determine CAT activity (Gorman et al., 1982). The per-
centage of acetylated chloramphenicol was quantified
using the automatic TLC linear analyzer of Berthold (Bad
Wildbad, Germany).
GST precipitation assays
GST-E1A12S fusion proteins were expressed in Esche-
richia coli BL21 bacteria and purified as described
(Brockmann et al., 1995). The human regulatory subunits
RIa, DRIa (lacking aa 1–45), RIIa, and DRIIa (lacking aa
–57) were purified as described (Eide et al., 1998; Her-
erg et al., 2000). Purified R-subunits were proteolytically
leaved as described before (Taske´n et al., 1993). For
ST pull-down assays, 10 mg of the appropriate GST-E1A
usion protein immobilized on glutathione–Sepharose
eads was incubated with 100,000 cpm of in vitro trans-
lated 35S-labeled RIa or RIIa. Binding reactions were
erformed in IP 1 150 buffer (50 mM HEPES/KOH, pH
.5, 150 mM KCl, 1 mM EDTA, 10 mM NaF, 1 mM Na3VO4,
0% glycerol, 0.1% NP-40, 0.5 mM Pefabloc, 10 mg/ml
protinin, 2 mg/ml BSA) for 1 h at 4°C. After extensive
ashings, interacting proteins were eluted with SDS
ample buffer, resolved on 10% SDS–polyacrylamide
els, and visualized by fluorography.
For direct interaction analyses, 1 mM of the respective
R-subunit was incubated with 1 mM of GST-E1A12S which
was immobilized on glutathione–Sepharose beads in PC
buffer (50 mM Tris/HCl, pH 7.4, 300 mM NaCl, 1 mM DTT,
1 mM EDTA, 5 mM benzamidine, 1 mM PMSF, 0.1%
Triton-X, and 10 mg/ml each protease inhibitor antipain,
hymostatin, leupeptin, and pepstatin A) (Herberg et al.,
000). In competition analyses, GST-E1A12S (50 nM) was
incubated with RIIa (50 nM) as described above in the
presence of the competitor peptide Ht31 (100 nM) or the
control peptide Ht31-P, where the binding helix motif is
disrupted by a proline (Carr et al., 1991). After washings,
interacting proteins were eluted with SDS sample buffer
and subjected to SDS–polyacrylamide gel electrophore-
sis and autoradiography.
Yeast SOS–two-hybrid assays
Preparation and transfection of competent Saccharo-
myces cerevisiae cdc-25-2 cells was performed as de-
scribed (Klebe et al., 1983; Aronheim et al., 1997). Cells
were plated on YNB-glucose minimal medium plates and
grown for 4 days at 25°C. Thereafter, four independent
transformants from each transfection were plated onto
YNB-glucose minimal medium plates and grown for an
additional 3 days at 25°C. Replica plating was performed
with ACCUTRAN replica plater (Schleicher & Schuell)
onto YNB-(1)-galactose plates. Plates were incubated
for 4 days at the selective temperature of 36°C.Antibodies
An anti-human Ca polyclonal antibody (C20, Santa
ruz Biotechnology), an anti-RIa polyclonal antibody
C19, Santa Cruz Biotechnology), an anti-RIIa polyclonal
antibody (C20, Santa Cruz Biotechnology), an anti-acetyl
histone H4 antibody (UBI), an anti-myc monoclonal anti-
body (Invitrogen), and an anti-CREB-1 monoclonal anti-
body (X12, Santa Cruz Biotechnology) were used at a
concentration of 1 mg/ml for Western blotting. The poly-
clonal sheep anti-Ad12 E1A antiserum was used in a
dilution of 1:5000. This antiserum recognizes specifically
the E1A proteins of Ad12. Recently developed monoclo-
nal antibodies directed against human RIa, human RIIa,
nd human RIIb (P53620, P55120, and P54720, devel-
ped by K. T. in collaboration with Transduction Labora-
ories, Lexington, KY), were used at a concentration of 1.0
mg/ml for immunoblot analysis and 2.5 mg/ml for immu-
nostaining (Eide et al., 1998). In addition, we used affinity-
purified rabbit anti-peptide antibodies to human RIb,
RIIa, and RIIb and purified anti-RIa mAb clone 4D7, all at
oncentrations of 1.0 mg/ml, for immunoprecipitations
(Taske´n et al., 1993; Skålhegg et al., 1992, 1994). All
ntibodies have been extensively characterized and
how good specificity and isoform selectivity (Taske´n et
al., 1993; Skålhegg et al., 1992, 1994).
Immunological procedures
COS7 cells (1.6 3 106) were transfected with expres-
sion vectors for FLAG- or myc/his-tagged wild-type
E1A12S or E1A12S mutants using polyfectin as described
above. For immunofluorescence analysis, cells grown on
glass coverslips were washed in PBS, fixed with 3%
paraformaldehyde for 15 min, permeabilized with 0.5%
Triton X-100 for 15 min, and blocked with 2% BSA in
PBS/0.01% Tween 20 (PBST). Cells were incubated for 30
min with primary and then with FITC- or TRITC-conju-
gated secondary antibodies, all at a 1:100 dilution in
PBST/2% BSA. After three washes in PBST, cells were
mounted and DNA counterstained with 0.1 mg/ml
Hoechst 33342. Observations were made on an Olympus
BX60 microscope using a 1003 objective, and photo-
raphs were taken with a JVC KY-F50E CCD camera and
nalySIS software (Soft Imaging System, Mu¨nster, Ger-
any).
For immunoprecipitations, cells were lysed in IP 1 150
buffer. Precleared lysates were incubated with the ap-
propriate antibodies at 4°C overnight. Protein complexes
were captured with protein A–Sepharose, washed three
times with IP 1 150 buffer, and eluted with SDS sample
buffer. Cytoplasmic and nuclear extracts of transfected
cells were prepared using a standard procedure (Dig-
nam et al., 1983) with minor modifications. Nuclear pel-
lets were washed twice with buffer B (20 mM Tris/HCl,
pH 7.5, 50 mM KCl, 0.1 mM EDTA, 1 mM DTT, 250 mM
sucrose, 0.5 mM pefabloc) and resuspended in extrac-
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40 FAX ET AL.tion buffer (20 mM Tris/HCl, pH 7.5, 420 mM KCl, 0.1 mM
EDTA, 1 mM DTT, 10 mM NaF, 1 mM Na3VO4, 0.5 mM
pefabloc). Protein complexes obtained by immunopre-
cipitation were analyzed by Western blotting as de-
scribed (Fax et al., 2000b). Blots were probed with anti-
bodies raised against RIa, PKA-Ca, RIIa, or Ad12 E1A.
nhanced chemiluminescence was carried out using the
uper Signal ultra Chemiluminescence detection system
Pierce).
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